These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6796508)

  • 1. Cycloheximide & mitomycin C inhibited production of dengue virus-induced suppressor factor.
    Shukla MI; Chaturvedi UC
    Indian J Exp Biol; 1981 Sep; 19(9):826-8. PubMed ID: 6796508
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of production of dengue virus induced cytotoxic factor by treatment with cycloheximide & mitomycin C.
    Dalakoti H; Chaturvedi UC; Mathur A
    Indian J Exp Biol; 1982 Jan; 20(1):1-3. PubMed ID: 6811426
    [No Abstract]   [Full Text] [Related]  

  • 3. Ly phenotype of T lymphocytes producing dengue virus-induced immunosuppressive factors.
    Shukla MI; Dalakoti H; Chaturvedi UC
    Indian J Exp Biol; 1982 Jul; 20(7):525-8. PubMed ID: 6217154
    [No Abstract]   [Full Text] [Related]  

  • 4. Abrogation of dengue virus-induced alterations of Fc-receptor functions of macrophages by splenectomy or drug treatment.
    Nagar R; Chaturvedi UC; Kumar A; Mathur A
    Indian J Med Res; 1985 Jun; 81():537-46. PubMed ID: 3932198
    [No Abstract]   [Full Text] [Related]  

  • 5. [Factors that control stem cell differentiation. II. The sensitivity of T-differentiated lymphocytes to the action of radiation and cytostatics].
    Man'ko VM; Saiadian KhS; Khalatian NA
    Tsitologiia; 1981 Mar; 23(3):333-9. PubMed ID: 6972648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of gamma-ray irradiation, DNA and protein synthesis inhibitors on the generation of soluble suppressor factors by mononuclear leukocytes].
    Shen HD; Shou L
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Sep; 16(3):207-13. PubMed ID: 6437771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein.
    Mota J; Acosta M; Argotte R; Figueroa R; Méndez A; Ramos C
    Vaccine; 2005 May; 23(26):3469-76. PubMed ID: 15837370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue virus-specific suppressor T cells: current perspectives.
    Chaturvedi UC; Shrivastava R; Tripathi RK; Nagar R
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):285-99. PubMed ID: 17573929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the production of dengue virus-induced macrophage cytotoxin.
    Chaturvedi UC; Gulati L; Mathur A
    Indian J Exp Biol; 1983 May; 21(5):275-9. PubMed ID: 6667980
    [No Abstract]   [Full Text] [Related]  

  • 10. Chromatin-organisation during and after synapsis in cultured microsporocytes of Lilium in presence of mitomycin C and cycloheximide.
    Sen SK
    Exp Cell Res; 1969 Apr; 55(1):123-7. PubMed ID: 5780785
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on dengue virus-induced cytotoxic factor.
    Dalakoti H; Chaturvedi UC; Mathur A
    Indian J Exp Biol; 1983 Jul; 21(7):375-8. PubMed ID: 6667993
    [No Abstract]   [Full Text] [Related]  

  • 12. Production and characterization of anti-dengue capsid antibodies suggesting the N terminus region covering the first 20 amino acids of dengue virus capsid protein is predominantly immunogenic in mice.
    Puttikhunt C; Ong-Ajchaowlerd P; Prommool T; Sangiambut S; Netsawang J; Limjindaporn T; Malasit P; Kasinrerk W
    Arch Virol; 2009; 154(8):1211-21. PubMed ID: 19565324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of E-rosette formation and phagocytosis by human blood leucocytes after treatment with the dengue virus-induced cytotoxic factor.
    Chaturvedi UC; Gulati L; Mathur A
    Immunology; 1982 Apr; 45(4):679-85. PubMed ID: 6978284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
    Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
    Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent enhancement in dengue virus infections.
    Burke DS; Kliks S
    J Infect Dis; 2006 Feb; 193(4):601-3; author reply 603-4. PubMed ID: 16425141
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of anticoagulants on the susceptibility of Aedes aegypti mosquitoes to dengue virus infection.
    Mourya DT
    Acta Virol; 2002; 46(1):51-3. PubMed ID: 12197636
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of macrophages and thymus in anti-dengue antibody production in mice.
    Murakami I
    Kobe J Med Sci; 1982 Feb; 28(1):33-46. PubMed ID: 7087367
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus.
    Izquierdo A; Bernardo L; Martin J; Santana E; Hermida L; Guillén G; Guzmán MG
    Virus Res; 2008 Dec; 138(1-2):135-8. PubMed ID: 18796319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring dengue enhancing antibodies: caveats.
    Halstead SB
    J Infect Dis; 2006 Feb; 193(4):601. PubMed ID: 16425142
    [No Abstract]   [Full Text] [Related]  

  • 20. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency.
    Chen MC; Lin CF; Lei HY; Lin SC; Liu HS; Yeh TM; Anderson R; Lin YS
    J Immunol; 2009 Aug; 183(3):1797-803. PubMed ID: 19592650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.